In order to positively affect health and health-related behaviors, we must understand why people and populations have certain behaviors. A good example is the risk that patients will misuse medication, either by self-treating with OTC medication or by not using prescribed medication as directed. We know that this behavior is somewhat linked to formal education level, an official SDoH measure, but we also know that there are other attitudinal and behavioral elements at play. For example, the level to which a patient trusts their doctor is an important attitudinal measure while their OTC medication consumption is an important behavioral measure. Unlike SDoH, with Comprehensive Determinants of Health (CDoH), providers and payers have the ability to directly address this risky behavior in patients and populations who show a high medication risk score.
When applying CDoH to their patients, providers and payers have the opportunity to intervene with their high-risk patients by having informed individual discussions as well as communications with patient groups. CDoH also measures preferred communication mediums allowing the providers to amplify their communications by choosing the most trusted form of media, messages, and messengers for their chosen population.
Another example of this use case involves the chronic disease cohort. Using CentraForce Health Intelligence Platform, healthcare professionals have the ability to use unique, record-level or cohort-level insights to understand why certain people with a chronic disease have the health outcomes they do. We know that some patients in the chronic disease cohort have good health outcomes, while others experience frequent ER visits and hospitalizations. For example, of 100,000 patients with congestive heart failure, 80,000 will do well while 20,000 are constantly in the hospital. Using CDoH behavioral insights, we can now understand why this is the case, even though they are physically indistinguishable.
Want to learn more about the CDoH approach? Download our Chronic Disease whitepaper for more information and insights.
Read previous blog -> SDoH: What Are The Limits?